© 1995 by Oxford University Press
Journal of the National Cancer Institute, Vol. 87, No. 1, 28-33,
January 4, 1995
© 1995 Oxford University Press
Cancer Risk After Hip Replacement With Metal Implants: a Population-Based Cohort Study in Sweden
*Department of Cancer Epidemiology, University Hospital Uppsala, Sweden
1National Cancer Institute Bethesda, Md
2Department of Orthopaedics, Malmo General Hospital Sweden
3Department of Cancer Epidemiology, University Hospital Uppsala; and Department of Epidemiology, Harvard School of Public Health Boston, Mass
Correspondence to: Olof Nyren, M.D., Ph.D., Department of Cancer Epidemiology, University Hospital, S-751 85 Uppsala, Sweden
Background: Joint replacement with metal implants has been the standard procedure for surgical treatment of irreversible degeneration of hip and knee joints for more than two decades. However, reports of local malignancy after joint replacement and experimental studies that suggest a carcinogenic action of metal ions and polymethylmethacry-late (an acrylic compound used to stabilize the implant in the host) have raised concern about the possible long-term risks associated with metal implants. Purpose: Our aim was to study cancer risk in a Swedish cohort of patients who had his replacement surgery during the period 1965 through 1983. Methods: We studied the risk of cancer in a cohort of 39 154 patients (14 869 men and 24 285 women), identified in the nationwide Swedish Inpatient Register with at least one hip replacement during the period 1965 through 1983. The patients were followed through 1989 by means of record linkage to the Swedish Cancer Register. The cohort contributed a total of 327 922 person-years at risk. Standardized incidence ratios (SIRs) were computed using age-, sex-, and period-specific incidence rates derived from the entire Swedish population. Results: The overall relative risk of cancer was increased by only 3%. Bone cancer-the focus of previous concerns-occurred in six cases versus 4.3 expected, and connective tissue cancer occurred in 28 cases versus 25.9 expected. Increases risks were observed for kidney cancer (SIR = 1.31; 95% confidence interval (CI) = 1.13–1.51), prostate cancer (SIR = 1.13; 95% CI = 1.04–1.22), and melanoma (SIR = 1.23; 95% CI = 1.00–1.50). The relative risk of gastric cancer steadily declined with increasing follow-up time, in both men and women (SIR = 0.58; 95% CI = 0.39–0.84 more than 10 years after hip replacement). Conclusion: In this study, the largest study to date to evaluate hip replacement and subsequent cancer risk, the overall cancer risk appears to be negligible from a public health perspective, and our results have not produced any strong evidence against the continued use of these devices. Nevertheless, the small but statistically significant increases in kidney and prostate cancers and the decrease in gastric cancer deserve further study. [J Natl Cancer Inst 87: 28-33, 1995]
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  F. Fang, F. Kamel, D. P. Sandler, P. Sparen, and W. Ye Maternal Age, Exposure to Siblings, and Risk of Amyotrophic Lateral Sclerosis Am. J. Epidemiol., June 1, 2008; 167(11): 1281 - 1286. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-W. Lee, B. Rickman, A. B. Rogers, Z. Ge, T. C. Wang, and J. G. Fox Helicobacter pylori Eradication Prevents Progression of Gastric Cancer in Hypergastrinemic INS-GAS Mice Cancer Res., May 1, 2008; 68(9): 3540 - 3548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Dunstan, D. Ladon, P. Whittingham-Jones, R. Carrington, and T.W.R. Briggs Chromosomal Aberrations in the Peripheral Blood of Patients with Metal-on-Metal Hip Bearings J. Bone Joint Surg. Am., March 1, 2008; 90(3): 517 - 522. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. L. Meyskens Jr. and M. Berwick UV or Not UV: Metals Are The Answer Cancer Epidemiol. Biomarkers Prev., February 1, 2008; 17(2): 268 - 270. [Full Text] [PDF]
|
|
|
|
|
|
F. Fang, W. Ye, K. Fall, M. Lekander, H. Wigzell, P. Sparen, H.-O. Adami, and U. Valdimarsdottir Loss of a Child and the Risk of Amyotrophic Lateral Sclerosis Am. J. Epidemiol., January 15, 2008; 167(2): 203 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Lidgren Chronic inflammation, joint replacement and malignant lymphoma J Bone Joint Surg Br, January 1, 2008; 90-B(1): 7 - 10. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Onega, J. Baron, and T. MacKenzie Cancer after Total Joint Arthroplasty: A Meta-analysis. Cancer Epidemiol. Biomarkers Prev., August 1, 2006; 15(8): 1532 - 1537. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Fall, W Ye, and O Nyren Antibiotic treatment and risk of gastric cancer Gut, June 1, 2006; 55(6): 793 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J. Bozic, R. G. Pierce, and J. H. Herndon Health Care Technology Assessment. Basic Principles and Clinical Applications J. Bone Joint Surg. Am., June 1, 2004; 86(6): 1305 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Feltelius, A Ekbom, and P Blomqvist Cancer incidence among patients with ankylosing spondylitis in Sweden 1965-95: a population based cohort study Ann Rheum Dis, December 1, 2003; 62(12): 1185 - 1188. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Ye and O Nyren Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia Gut, July 1, 2003; 52(7): 938 - 941. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. U. Cope, J. Askling, G. Gridley, A. Mohr, A. Ekbom, O. Nyren, and M. S. Linet Appendectomy During Childhood and Adolescence and the Subsequent Risk of Cancer in Sweden Pediatrics, June 1, 2003; 111(6): 1343 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Ye, J Lagergren, E Weiderpass, O Nyren, H-O Adami, and A Ekbom Alcohol abuse and the risk of pancreatic cancer Gut, August 1, 2002; 51(2): 236 - 239. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W Ye, J Lagergren, O Nyren, and A Ekbom Risk of pancreatic cancer after cholecystectomy: a cohort study in Sweden Gut, November 1, 2001; 49(5): 678 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. B. Signorello, W. Ye, J. P. Fryzek, L. Lipworth, J. F. Fraumeni Jr., W. J. Blot, J. K. McLaughlin, and O. Nyren Nationwide Study of Cancer Risk Among Hip Replacement Patients in Sweden J Natl Cancer Inst, September 19, 2001; 93(18): 1405 - 1410. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Weiderpass, W. Ye, R. Tamimi, D. Trichopolous, O. Nyren, H. Vainio, and H.-O. Adami Alcoholism and Risk for Cancer of the Cervix Uteri, Vagina, and Vulva Cancer Epidemiol. Biomarkers Prev., August 1, 2001; 10(8): 899 - 901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Tharani, F. J. Dorey, and T. P. Schmalzried The Risk of Cancer Following Total Hip or Knee Arthroplasty J. Bone Joint Surg. Am., May 1, 2001; 83(5): 774 - 780. [Full Text] [PDF]
|
|
|
|
|
|
K. Akre, L. B. Signorello, L. Engstrand, R. Bergström, S. Larsson, B. I. Eriksson, and O. Nyrén Risk for Gastric Cancer after Antibiotic Prophylaxis in Patients Undergoing Hip Replacement Cancer Res., November 1, 2000; 60(22): 6376 - 6380. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. JACOBS, A. K. SKIPOR, L. M. PATTERSON, N. J. HALLAB, W. G. PAPROSKY, J. BLACK, and J. O. GALANTE Metal Release in Patients Who Have Had a Primary Total Hip Arthroplasty. A Prospective, Controlled, Longitudinal Study J. Bone Joint Surg. Am., October 1, 1998; 80(10): 1447 - 58. [Abstract] [Full Text]
|
|
|
|
|
|
J. J. JACOBS, J. L. GILBERT, and R. M. URBAN Current Concepts Review - Corrosion of Metal Orthopaedic Implants J. Bone Joint Surg. Am., February 1, 1998; 80(2): 268 - 82. [Full Text]
|
|
|
|
 |
|
 L.-E. Hansson, O. Nyren, A. W. Hsing, R. Bergstrom, S. Josefsson, W.-H. Chow, J. F. Fraumeni, and H.-O. Adami The Risk of Stomach Cancer in Patients with Gastric or Duodenal Ulcer Disease N. Engl. J. Med., July 25, 1996; 335(4): 242 - 249. [Abstract] [Full Text] [PDF]
|
|